ARCT
NASD Arcturus Therapeutics Holdings, Inc.$10.22 ↓ -0.12 (-1.16%) Trading Down from the previous close of $10.34
- YTD change
- +66.72%
- vs 20-day SMA
- -22.23%
- vs 200-day SMA
- +16.18%
Price ranges
Price & Performance
+1.44 (+16.18%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 92.4% away from all-time highs of $134.75
- ARCT is up 67% since the beginning of the year
- ARCT is down 51% over the past 12 months
- ARCT is down 36% over the past 1 month
- 22% of all ARCT investors are betting against ARCT
ARCT reads poor: price sits above one of the two key moving averages, the 12-month move is -51.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.12
- Last 5 days
- -25.62%
- vs 8-day SMA
- -15.49%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.